This dual-action approach makes Tirzepatide unique and potentially more effective in managing blood sugar levels and weight
That might sound familiar, because GLP-1 medications also reduce appetite and slow gastric emptying
Although generally safe, risks to also consider are allergic reactions, use during pregnancy, and low blood sugar levels.7 The mechanism of GLP-1 & GIP agonist has offered a multifaceted approach to treating both type 2 diabetes and obesity
The warning also states that taking higher doses than needed can cause serious or life-threatening toxic effects
Prematurity and low birth weight in neonates as a risk factor for obesity, hypertension, and chronic kidney disease in pediatric and adult age
Newswise A medication commonly used to treat Type 2 diabetes and obesity was associated with a slight increase in risk for a rare condition involving reduced blood flow to the optic nerve that can cause sudden vision loss, according to Rutgers researchers